198 related articles for article (PubMed ID: 7807176)
21. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.
Fan YF; Huang ZH
World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629
[TBL] [Abstract][Full Text] [Related]
22. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
24. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.
Morita T; Shinohara N; Tokue A
Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
[TBL] [Abstract][Full Text] [Related]
26. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.
Takamiya Y; Brem H; Ojeifo J; Mineta T; Martuza RL
Neurosurgery; 1994 May; 34(5):869-75; discussion 875. PubMed ID: 8052385
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy.
Konno H
Cancer Chemother Pharmacol; 1999; 43 Suppl():S85-9. PubMed ID: 10357565
[TBL] [Abstract][Full Text] [Related]
28. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia.
Kria L; Ohira A; Amemiya T
Curr Eye Res; 1998 Oct; 17(10):986-93. PubMed ID: 9788301
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470.
Ohta Y; Watanabe Y; Tabata T; Oda M; Hayashi Y; Endo Y; Tanaka M; Sasaki T
Br J Cancer; 1997; 75(4):512-5. PubMed ID: 9052402
[TBL] [Abstract][Full Text] [Related]
30. A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.
Okrój M; Kamysz W; Slominska EM; Mysliwski A; Bigda J
Anticancer Drugs; 2005 Sep; 16(8):817-23. PubMed ID: 16096429
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
32. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
Murata R; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma.
Fujioka T; Hasegawa M; Ogiu K; Matsushita Y; Sato M; Kubo T
J Urol; 1996 May; 155(5):1775-8. PubMed ID: 8627882
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
35. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.
Ogawa H; Sato Y; Kondo M; Takahashi N; Oshima T; Sasaki F; Une Y; Nishihira J; Todo S
Oncol Rep; 2000; 7(3):467-72. PubMed ID: 10767353
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.
Morales C; Zurita M; Vaquero J
J Neurooncol; 2002 Jun; 58(2):131-6. PubMed ID: 12164684
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.
Yanase T; Tamura M; Fujita K; Kodama S; Tanaka K
Cancer Res; 1993 Jun; 53(11):2566-70. PubMed ID: 7684319
[TBL] [Abstract][Full Text] [Related]
38. TNP-470 is an effective antimicrosporidial agent.
Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
